Sansanmycin natural product analogues as potent and selective anti-mycobacterials that inhibit lipid I biosynthesis. (2017)
Attributed to:
Enabling exploitation of novel reagents and assays (EnRgy) to target the inhibition of peptidoglycan biosynthesis
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/ncomms14414
PubMed Identifier: 28248311
Publication URI: http://europepmc.org/abstract/MED/28248311
Type: Journal Article/Review
Volume: 8
Parent Publication: Nature communications
ISSN: 2041-1723